ProteinQure
Biotech company using AI and computational platforms to design novel peptide therapeutics.
About
Technology stack
detected 2026-05-23No comments yet. Be the first to share your take.
What does ProteinQure do?
ProteinQure is a clinical-stage biotechnology company that leverages its proprietary computational platform, ProteinStudio™, to design novel peptide therapeutics. Their platform integrates machine learning, structural biology, and atomic-level simulations to create peptide-drug conjugates for diseases like cancer. They are advancing a pipeline of internal and partnered drug discovery projects, with a focus on precision medicine and targeted drug delivery.
How much funding has ProteinQure raised?
ProteinQure has raised a total of $16M in funding. The most recent round on record is Series A.
Where is ProteinQure headquartered?
ProteinQure is headquartered in Cambridge, United States.
When was ProteinQure founded?
ProteinQure was founded in 2017.
What industry does ProteinQure operate in?
ProteinQure operates in Biotech, Drug Discovery, AI-Driven Protein Design, Clinical Trials, Peptide Therapeutics, Machine Learning.
How many employees does ProteinQure have?
ProteinQure has approximately 32 people on record.
What is ProteinQure's current status?
ProteinQure's current operating status is: Inactive.